O4I2
CAS No. 165682-93-9
O4I2( O4I2 | O-4I2 | O4I-2 )
Catalog No. M17360 CAS No. 165682-93-9
O4I2 is an effective Oct3/4 inducer in various human cell lines including human fibroblasts.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 106 | In Stock |
|
| 50MG | 178 | In Stock |
|
| 100MG | 332 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameO4I2
-
NoteResearch use only, not for human use.
-
Brief DescriptionO4I2 is an effective Oct3/4 inducer in various human cell lines including human fibroblasts.
-
DescriptionO4I2 is a potent inducers of Oct3/4. O4I2 showed high activity in enforcing Oct3/4 expression. O4I2 is a new class of small molecules suitable for iPSC generation. The octamer-binding transcription factor 4 (Oct3/4) is a master gene in the transcriptional regulatory network of pluripotent cells. Repression of Oct3/4 in embryonic stem cells (ESCs) is associated with cell differentiation and loss of pluripotency, whereas forced overexpression in cooperation with other transcriptional factors, such as Nanog, Sox2, and Lin28, can reprogram somatic cells back into pluripotent cells, termed induced pluripotent stem cells (iPSCs).
-
In VitroO4I2 not only promotes Oct3/4 expression by activating its promoter site, but also stabilize the Oct3/4 protein in HEK293 cells.O4I2 markedly stimulates Oct3/4 even at 5 μM after 72 hrs treatment on the translational level.O4I2 (20 μM) accumulates Oct3/4 in NCCIT occurred already 2 hrs after incubation, while the detectable Sox2 increase appears much later, implicating compound-mediated activation of Oct3/4 might be different between embryonic kidney HEK293 cells and embryonal carcinoma NCCIT cells. Immunofluorescence Cell Line:HF (human fibroblasts) cells.Concentration:5-20 μM.Incubation Time:5 days.Result:Successfully detected co-expression of Oct3/4 and Sox2, as well as Nanog and Klf4.
-
In Vivo——
-
SynonymsO4I2 | O-4I2 | O4I-2
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
RecptorOCT3| OCT4
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number165682-93-9
-
Formula Weight282.75
-
Molecular FormulaC12H11ClN2O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 42 mg/mL; 148.54 mM
-
SMILESCCOC(=O)c1csc(n1)Nc1ccc(cc1)Cl
-
Chemical Nameethyl 2-((4-chlorophenyl)amino)thiazole-4-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cheng X, et al. J Med Chem. 2015 Aug 13;58(15):5742-5750.
molnova catalog
related products
-
GNE-9815
GNE-9815 is a high kinase-selective inhibitor of RAF and targets KRAS-mutant cancers through combination therapy.
-
SU6656
SU 6656 is a selective inhibitor of Src family kinases, with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.
-
Plx-4032
PLX-4032 is a small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma.PLX-4032 and its related analogs are highly potent inhibitors of B-Raf activity, with 3-fold selectivity for the V600E mutation over the wild-type kinase.
Cart
sales@molnova.com